Vivian Hou Chu, MD

Associate Professor
Member in the Duke Clinical Research Institute
Campus mail Duke Box 102359, DIV of Infectious Diseases, Durham, NC 27710
Phone (919) 668-7174
Email address vivian.chu@duke.edu

Dr. Chu's clinical research is focused on staphylococci and endocarditis (IE).  She is the director of the International Collaboration on Endocarditis (ICE), a group of investigators from 78 sites in 32 countries worldwide that is dedicated to further the understanding of infective endocarditis.  The ICE database comprises > 5000 cases of endocarditis and is designed to answer questions that could not be answered from a single-center study. The current focus of this group is surgical-decision making in the treatment of endocarditis. Another major focus of Dr. Chu's research is on the relationship between oral hygiene and risk for developing infective endocarditis.

Education and Training

  • Fellow in Infectious Diseases, Medicine, Duke University, 2003 - 2006
  • Medical Resident, Medicine, Duke University, 2000 - 2003
  • M.D., Columbia University, 2000

Publications

El-Ahdab, Fadi, Daniel Kelly Benjamin, Andrew Wang, Christopher H. Cabell, Vivian H. Chu, Martin E. Stryjewski, G Ralph Corey, Daniel J. Sexton, L Barth Reller, and Vance G. Fowler. “Risk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremia..” Am J Med 118, no. 3 (March 2005): 225–29. https://doi.org/10.1016/j.amjmed.2004.12.017.

PMID
15745719
Full Text

Chu, Vivian H., Christopher H. Cabell, Elias Abrutyn, G Ralph Corey, Bruno Hoen, Jose M. Miro, Lars Olaison, et al. “Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged Database..” Clin Infect Dis 39, no. 10 (November 15, 2004): 1527–30. https://doi.org/10.1086/424878.

PMID
15546091
Full Text

Chu, V. H., H. Cabell, J. Y. Friedman, S. D. Reed, R. I. Griffiths, K. S. Kaye, D. R. Crosslin, et al. “The clinical and economic impact of Staphylococcus aureus bacteremia in patients with cardiovascular devices.” In Circulation, 110:566–566. LIPPINCOTT WILLIAMS & WILKINS, 2004.

Scholars@Duke

Chu, V. H., C. H. Cabell, D. K. Benjamin, E. F. Kuniholm, V. G. Fowler, J. Engemann, D. J. Sexton, G. R. Corey, and A. Wang. “Infective endocarditis: Should diabetic patients be treated more aggressively? Response.” Circulation 110, no. 7 (August 17, 2004): E72–E72.

Scholars@Duke

Stryjewski, Martin E., Vivian H. Chu, Christopher H. Cabell, and Vance G. Fowler. “Issues in the Management of Endocarditis Caused by Resistant Gram-positive Organisms..” Curr Infect Dis Rep 6, no. 4 (August 2004): 283–91.

PMID
15265456
Scholars@Duke

Chu, Vivian H., Christopher H. Cabell, Daniel K. Benjamin, Erin F. Kuniholm, Vance G. Fowler, John Engemann, Daniel J. Sexton, G Ralph Corey, and Andrew Wang. “Early predictors of in-hospital death in infective endocarditis..” Circulation 109, no. 14 (April 13, 2004): 1745–49. https://doi.org/10.1161/01.CIR.0000124719.61827.7F.

PMID
15037538
Full Text

Cabell, Christopher H., Paul A. Heidenreich, Vivian H. Chu, Christopher M. Moore, Martin E. Stryjewski, G Ralph Corey, and Vance G. Fowler. “Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999..” Am Heart J 147, no. 4 (April 2004): 582–86. https://doi.org/10.1016/j.ahj.2003.06.005.

PMID
15077071
Full Text

Pages